Literature DB >> 3047927

Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?

B H Markus1, R J Duquesnoy, R D Gordon, J J Fung, M Vanek, G Klintmalm, C Bryan, D Van Thiel, T E Starzl.   

Abstract

An analysis of more than 500 liver transplants has demonstrated that HLA compatibility is associated with diminished allograft survival. Liver transplants with zero mismatches for class I and/or class II HLA antigens have shown significantly lower actuarial survival rates than transplants with one or more mismatches for these loci. In a group of 119 failed liver allografts from patients undergoing retransplantation, a higher incidence of failure due to rejection correlated with a lower degree of HLA compatibility especially for HLA-DR. In contrast, the incidence of liver transplant failures due to primary nonfunction was relatively higher with HLA-DR compatible transplants. Considering the role of HLA as a restriction element in cellular interactions during the immune response, these findings suggest that HLA compatibility may have a dualistic effect on liver transplant outcome. On one hand, HLA compatibility reduced transplant rejection--and on the other hand, it may enhance other immunological mechanisms leading to allograft dysfunction, particularly in patients at risk of developing recurrent autoimmune diseases or infection.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3047927      PMCID: PMC2956422     

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  56 in total

1.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

2.  The influence of HLA matching in cardiac allograft recipients receiving cyclosporine and azathioprine.

Authors:  M Yacoub; H Festenstein; P Doyle; M Martin; D McCloskey; J Awad; A Gamba; A Khaghani; J Holmes
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

Review 3.  The human immune response region (HLA-D) and disease susceptibility.

Authors:  P Stastny; E J Ball; P J Dry; G Nunez
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

4.  Primary or secondary sicca complex? Investigation in primary biliary cirrhosis by histocompatibility testing.

Authors:  A N Hamlyn; D Adams; S Sherlock
Journal:  Br Med J       Date:  1980-08-09

5.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection.

Authors:  A J Demetris; R Jaffe; D G Sheahan; J Burnham; J Spero; S Iwatsuki; D H Van Theil; T E Starzl
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

6.  Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation.

Authors:  P T Donaldson; G J Alexander; J O'Grady; J Neuberger; B Portmann; M Thick; H Davis; R Y Calne; R Williams
Journal:  Lancet       Date:  1987-04-25       Impact factor: 79.321

7.  Association of primary sclerosing cholangitis with HLA-B8.

Authors:  R W Chapman; Z Varghese; R Gaul; G Patel; N Kokinon; S Sherlock
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

8.  Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. I. Lysis restricted by HLA class II MB and DR antigens.

Authors:  M Yasukawa; J M Zarling
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

9.  De novo and recurrent membranous glomerulopathy following kidney transplantation.

Authors:  B E Berger; F Vincenti; C Biava; W J Amend; N Feduska; O Salvatierra
Journal:  Transplantation       Date:  1983-04       Impact factor: 4.939

10.  Role of liver transplantation in cancer therapy.

Authors:  S Iwatsuki; R D Gordon; B W Shaw; T E Starzl
Journal:  Ann Surg       Date:  1985-10       Impact factor: 12.969

View more
  21 in total

1.  HLA matching effect in liver transplantation.

Authors:  A Yagihashi; M Kobayashi; K Noguchi; A Konno; Y Yoshida; K Terasawa; T E Starzl; Y Iwaki
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

Review 2.  Cell migration, chimerism, and graft acceptance.

Authors:  T E Starzl; A J Demetris; N Murase; S Ildstad; C Ricordi; M Trucco
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

Review 3.  Impact of human leukocyte antigen mismatching on outcomes of liver transplantation: a meta-analysis.

Authors:  Xiang Lan; Ming-Man Zhang; Cong-Lun Pu; Chun-Bao Guo; Quan Kang; Ying-Chun Li; Xiao-Ke Dai; Yu-Hua Deng; Qiang Xiong; Zhi-Mei Ren
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

4.  HLA matching and the point system.

Authors:  Thomas E Starzl; Anthony J Demetris; Massimo Trucco
Journal:  Clin Transplant       Date:  1993       Impact factor: 2.863

5.  Transplantation.

Authors:  T E Starzl
Journal:  JAMA       Date:  1989-05-19       Impact factor: 56.272

Review 6.  Perspectives in transplantation immunology 1991.

Authors:  D Kabelitz; M L da Silva Lobo; K Pechhold
Journal:  Klin Wochenschr       Date:  1991-09-03

Review 7.  Liver transplantation.

Authors:  J G O'Grady; B Portmann
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

8.  Association between donor-recipient HLA-DR compatibility and cytomegalovirus hepatitis and chronic rejection in liver transplantation.

Authors:  R Mañez; L T White; S Kusne; M Martin; A J Demetris; T E Starzl; R J Duquesnoy
Journal:  Transplant Proc       Date:  1993-02       Impact factor: 1.066

Review 9.  Chronic rejection. A general overview of histopathology and pathophysiology with emphasis on liver, heart and intestinal allografts.

Authors:  A J Demetris; N Murase; R G Lee; P Randhawa; A Zeevi; S Pham; R Duquesnoy; J J Fung; T E Starzl
Journal:  Ann Transplant       Date:  1997       Impact factor: 1.530

10.  The impact of human leukocyte antigen donor and recipient serotyping and matching on liver transplant graft failure in primary sclerosing cholangitis, autoimmune hepatitis, and primary biliary cholangitis.

Authors:  Yuval A Patel; Jacqueline B Henson; Julius M Wilder; Jiayin Zheng; Schein-Chung Chow; Carl L Berg; Stuart J Knechtle; Andrew J Muir
Journal:  Clin Transplant       Date:  2018-09-15       Impact factor: 2.863

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.